Skip to main content
Caplight Logo









MC2 Therapeutics

MC2 Therapeutics

Private
HørsholmHealthcare & Life Scienceshttps://mc2therapeutics.com/

Company Overview

MC2 Therapeutics operates in Healthcare & Life Sciences and is based in Hørsholm. It was founded in 2006.

MC2 Therapeutics is a pharmaceutical company that develops innovative topical therapies for immune-mediated and inflammatory skin conditions using its proprietary PAD Technology™.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MC2 Therapeutics Comparables

Compare MC2 Therapeutics with similar companies based on industry and business-model similarity.

MC2 Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LEO Pharma
78%
Organon & Co.
76%
EPI Health, LLC
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MC2 Therapeutics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for MC2 Therapeutics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Trine Svejborg Holmvang

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2024

    Monthly visitors increased 36% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

MC2 Therapeutics Filings

Explore SEC and related filing metadata, where available.

MC2 Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MC2 Therapeutics's valuation, stock price, and market status.

Is MC2 Therapeutics a public or private company?

MC2 Therapeutics is a private company.

What is the current stock price of MC2 Therapeutics?

MC2 Therapeutics is a private company, so its shares have no public market price. Caplight tracks MC2 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MC2 Therapeutics worth (valuation)?

Valuation information for MC2 Therapeutics is not publicly available.

Can I buy MC2 Therapeutics stock?

MC2 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MC2 Therapeutics's last funding round?

Funding round information for MC2 Therapeutics is not publicly available.

Who are the main investors in MC2 Therapeutics?

Investor information for MC2 Therapeutics is not publicly disclosed.

Will MC2 Therapeutics IPO soon?

No public IPO plans have been announced for MC2 Therapeutics.

How can I track MC2 Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in MC2 Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersHørsholm
Employee Range21
Year Founded2006
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?